Chinese cancer drug developer Biostar closes $135m pre-IPO round

Chinese cancer drug developer Biostar closes $135m pre-IPO round

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter